Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. TO /
  3. FRX.TO

Fennec Pharmaceuticals Inc (FRX TO) stock market data APIs

C$9.29 0.06(0.7%) as of July 26, 2024
Price chart is built with Anychart

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Fennec Pharmaceuticals Inc Financial Data Overview

9.42
9.29
-
9.43
8.77
7.8-15.43
248 M
151.3333
27 322 K
44 952 K
0.5568
0.29
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'FRX',
Type: 'Common Stock',
Name: 'Fennec Pharmaceuticals Inc',
Exchange: 'TO',
CurrencyCode: 'CAD',
CurrencyName: 'Canadian Dollar',
CurrencySymbol: 'C$',
CountryName: 'Canada',
CountryISO: 'CA',
OpenFigi: NULL,
ISIN: 'CA31447P1009',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Fennec Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 44 952 K
  • EBITDA -13 009 000
  • Earnings Per Share 0.06
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Fennec Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast NaN

Get Fennec Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Fennec Pharmaceuticals Inc latest news via APIs

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Com...
  • CALENDAR OF EVENTS
  • FENNEC PHARMACEUTICALS INC
  • TORONTO STOCK EXCHANGE:FRX

Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update

~ PEDMARK® Net Product Revenue of $6.5 Million, a 96% Increase Compared to Second Quarter ~ ~ Strong Commercial Uptake Underscoring Significant Unmet Medical Need ~ ~ Received Approval in October 2...
  • EARNINGS RELEASES AND OPERATING RESULTS
  • FENNEC PHARMACEUTICALS INC
  • TORONTO STOCK EXCHANGE:FRX
Do you have any questions?
support@eodhistoricaldata.com